Presented By: Osher Lifelong Learning Institute (50+)
Stem Cell Therapy for Neurological Diseases: Where Are We Now?
Eva Feldman
Dr. Feldman received her M.D. and PhD degrees from the University of Michigan, completed a neurological residency at the Johns Hopkins Hospital and returned to U of M for a Neuromuscular fellowship. In January 2008, Dr. Feldman was named the first Director of the A. Alfred Taubman Medical Research Institute, which was created to support fundamental research into a wide range of human diseases. Under her leadership the Taubman Institute funds scientists in a diverse
spectrum of diseases-adult and childhood cancer, amyotrophic lateral sclerosis (ALS), cardiovascular disease and hearing loss. In her own work, Dr. Feldman is on the forefront of applying stem-cell research to human disease.
Dr. Feldman will provide ann overview of research in this field. In particular she will describe her own work as the Principal Investigator of the first clinical trial of intraspinal transplantation of stem cells in patients with ALS.
This is the last in OLLI’S distinguished lecture series for 2017-18. A variety of topics have been covered.
spectrum of diseases-adult and childhood cancer, amyotrophic lateral sclerosis (ALS), cardiovascular disease and hearing loss. In her own work, Dr. Feldman is on the forefront of applying stem-cell research to human disease.
Dr. Feldman will provide ann overview of research in this field. In particular she will describe her own work as the Principal Investigator of the first clinical trial of intraspinal transplantation of stem cells in patients with ALS.
This is the last in OLLI’S distinguished lecture series for 2017-18. A variety of topics have been covered.
Cost
- $10 for an individual lecture, payable at the door, checks preferred. $25 for 5 lectures through January, or $50 for all 10 lectures through June, or $165 for an all-lecture package (10 distinguished lectures plus 33 Thursday lectures).
Related Links
Explore Similar Events
-
Loading Similar Events...